XENETIC BIOSCIENCES, INC.: 10-Q filed 2012-07-16

Name: XENETIC BIOSCIENCES, INC.: 10-Q filed 2012-07-16
Creator: XENETIC BIOSCIENCES, INC.

What XENETIC BIOSCIENCES, INC. reported in its quarterly report filed 2012-07-16 (fiscal Q3 2012): 18 published measures, 37 facts as tagged in accession 0001255294-12-000500.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-07-16
Fiscal period: fiscal Q3 2012
Accession: 0001255294-12-000500 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XENETIC BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-05-31	303,856	USD
At 2011-08-31	222,500	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-05-31	-49,526	USD
At 2011-08-31	1,765	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-09-01 to 2012-05-31	-86,291	USD	274
2011-08-09 to 2012-05-31	-94,526	USD	297

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-09-01 to 2012-05-31	-11,944	USD	274
2011-08-09 to 2012-05-31	-12,257	USD	297

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-08-09 to 2012-05-31	-212,500	USD	297

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-03-01 to 2012-05-31	36,430	USD	92
2011-09-01 to 2012-05-31	86,146	USD	274
2011-08-09 to 2012-05-31	86,146	USD	297

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-09-01 to 2012-05-31	35,000	USD	274
2011-08-09 to 2012-05-31	257,813	USD	297

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-08-09 to 2012-05-31	-212,500	USD	297

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-03-01 to 2012-05-31	12,130,435	shares	92
2011-09-01 to 2012-05-31	10,715,328	shares	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-05-31	198,332	USD
At 2011-08-31	212,500	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-03-01 to 2012-05-31	-35,626	USD	92
2011-09-01 to 2012-05-31	-76,511	USD	274
2011-08-09 to 2012-05-31	-83,885	USD	297

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-05-31	105,524	USD
At 2011-08-31	10,000	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-03-01 to 2012-05-31	-3,232	USD	92
2011-09-01 to 2012-05-31	-9,780	USD	274
2011-08-09 to 2012-05-31	-10,641	USD	297

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-05-31	140,569	USD
At 2011-08-31	7,922	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-03-01 to 2012-05-31	72,056	USD	92
2011-09-01 to 2012-05-31	162,657	USD	274
2011-08-09 to 2012-05-31	170,031	USD	297

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-05-31	31,500	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2011-09-01 to 2012-05-31	14,168	USD	274
2011-08-09 to 2012-05-31	14,168	USD	297

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-09-01 to 2012-05-31	-72,468	USD	274
2011-08-09 to 2012-05-31	-72,468	USD	297

Inspect the source

Entity: XENETIC BIOSCIENCES, INC. / CIK 0001534525
Captured: 2026-09-20T09:16:43.632Z
SEC response SHA-256: 0d9d849e14a36c3c398086c2983f13053152bb5ab9dbb765c6ab6226c86b34ff

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001534525.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))